Locked
Covid-19 vaccine pharma execs cash in big time – With insights from The Wall Street Journal
'Executives at Moderna, Merck are among those who have reaped the biggest rewards', reports Inti Pacheco of The Wall Street Journal.
There have been a lot more losers than winners in the Covid-19 pandemic. Notable among the beneficiaries are executives in Big Pharma, many of whom have made fortunes through incentive schemes linked to the share prices of their employers. Now they're selling. And if insiders offload, other investors should pay attention. Here's the story from from our partners at The Wall Street Journal.
Use Spotify? Access BizNews podcasts here.
Use Apple Podcasts? Access BizNews podcasts here.
___STEADY_PAYWALL___